Invention Grant
- Patent Title: Anti IL-34 antibodies
-
Application No.: US15536962Application Date: 2015-12-21
-
Publication No.: US10703813B2Publication Date: 2020-07-07
- Inventor: Dominique Heymann , Aude Segaliny , Régis Brion
- Applicant: Universite de Nantes , Chu Nantes , Institut National de la Sante et de la Recherche Medicale (INSERM)
- Applicant Address: FR Nantes FR Nantes FR Paris
- Assignee: UNIVERSITE DE NANTES,CHU NANTES,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
- Current Assignee: UNIVERSITE DE NANTES,CHU NANTES,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
- Current Assignee Address: FR Nantes FR Nantes FR Paris
- Agency: Buchanan Ingersoll & Rooney PC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@f98dd33
- International Application: PCT/EP2015/080866 WO 20151221
- International Announcement: WO2016/097420 WO 20160623
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24 ; C12N15/24 ; G01N33/68
Abstract:
The present disclosure relates to novel anti IL-34 antibodies or antigen-binding fragments thereof specifically binding cytokine IL-34 with high affinity, the method of obtaining of these antibodies and their therapeutic use.
Public/Granted literature
- US20170342148A1 ANTI IL-34 ANTIBODIES Public/Granted day:2017-11-30
Information query
